Michel Lockhart

Michel Lockhart is CEO of Chitolytic, a specialized chitosan manufacturer and supplier that transforms shrimp processing byproducts into high-value applications. With over 40 years in the life sciences sector, beginning with major pharmaceutical companies like Johnson & Johnson and Sanofi, he has played a key role in launching and scaling numerous successful ventures, products, and partnerships across marine biotech and in different countries.  Michel brings deep expertise in commercializing shrimp-derived products such as chitosan and hydrolyzed shrimp, and continues to lead Chitolytic to drive innovation and market adoption of products globally across the medical, biomaterials, food, consumer, agriculture, and industrial sectors.